Directori de persones
Judit Pallares Quixal

Judit Pallares Quixal

Grau: Doctor/a


jpallares.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/A-6635-2010

Publicacions

  • Gatius, S; Azueta, A; Velasco, A; Santacana, M; Pallares, J; Matias-Guiu, X

    FGFR2 Alterations in Endometrial Carcinoma.

    LABORATORY INVESTIGATION 91 442-442. .

  • Aguayo, Rafael; Pallares, Judit; Casanova, Josep M.; Baradad, Manel; Sanmartin, Veronica; Moreno, Sara; Egido, Ramon; Marti, Rosa M.

    Squamous cell carcinoma developing in Jadassohn's sebaceous nevus: case report and review of the literature.

    Dermatologic Surgery 36 1763-1768. .

    [doi:10.1111/j.1524-4725.2010.01746.x]

  • Llobet, D.; Eritja, N.; Yeramian, A.; Pallares, J.; Sorolla, A.; Domingo, M.; Santacana, M.; Gonzalez-Tallada, F. J.; Matias-Guiu, X.; Dolcet, X.

    The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms.

    EUROPEAN JOURNAL OF CANCER 46 836-850. .

    [doi:10.1016/j.ejca.2009.12.025]

  • Llobet, D.; Pallares, J.; Yeramian, A.; Santacana, M.; Eritja, N.; Velasco, A.; Dolcet, X.; Matias-Guiu, X.

    Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints.

    JOURNAL OF CLINICAL PATHOLOGY 62 777-785. .

    [doi:10.1136/jcp.2008.056101]

  • Pallares, Judit; Santacana, Maria; Puente, Soraya; Lopez, Susana; Yeramian, Andree; Eritja, Nuria; Sorolla, Anabel; Llobet, David; Dolcet, Xavier; Matias-Guiu, Xavier

    A review of the applications of tissue microarray technology in understanding the molecular features of endometrial carcinoma.

    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY 31 217-226. .

  • Pallares, Judit; Llobet, David; Santacana, Maria; Eritja, Nuria; Velasco, Ana; Cuevas, Dolors; Lopez, Susana; Palomar-Asenjo, Victor; Yeramian, Andree; Dolcet, Xavier; Matias-Guiu, Xavier

    CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation.

    AMERICAN JOURNAL OF PATHOLOGY 174 287-296. .

    [doi:10.2353/ajpath.2009.080552]

  • Ortega, Eugenia; Marti, Rosa M.; Yeramian, Andree; Sorolla, Anabel; Dolcet, Xavier; Llobet, David; Abal, Leandro; Santacana, Maria; Pallares, Judit; Llombart-Cussac, Antonio; Matias-Guiu, Xavier

    Targeted therapies in gynecologic cancers and melanoma.

    SEMIN DIAGN PATHOL 25 262-273. .

    [doi:10.1053/j.semdp.2008.07.008]

  • Puente, Soraya; Velasco, Ana; Gallel, Pilar; Pallares, Judit; Perez-Ruiz, Luis; Ros, Susana; Maravall, Javier; Matias-Guiu, Xavier

    Metastatic small cell carcinoma to the thyroid gland: a pathologic and molecular study demonstrating the origin in the urinary bladder.

    ENDOCRINE PATHOLOGY 19 190-196. .

    [doi:10.1007/s12022-008-9024-4]

  • Gallel, Pitar; Pallares, Judit; Dolcet, Xavier; Llobet, David; Eritja, Nuria; Santacana, Maria; Yeramian, Andre; Palomar-Asenjo, Victor; Lagarda, Helena; Mauricio, Didac; Encinas, Mario; Matias-Guiu, Xavier

    Nuclear factor-kappaB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma.

    HUMAN PATHOLOGY 39 994-1001. .

    [doi:10.1016/j.humpath.2007.11.015]

  • Velasco, Ana; Pallares, Judit; Santacana, Maria; Yeramian, Andre; Dolcet, Xavier; Eritja, Nuria; Puente, Soraya; Sorolla, Anabel; Llecha, Nuria; Matias-Guiu, Xavier

    Loss of heterozygosity in endometrial carcinoma

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 27 305-317. .

    [doi:10.1097/PGP.0b013e31815dafla]

  • Velasco A; Pallares J; Santacana M; Yeramian A; Dolcet X; Eritja N; Puente S; Sorolla A; Llecha N; Matias-Guiu X

    Loss of heterozygosity in endometrial carcinoma.

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 27 305-317. .

    [doi:10.1097/PGP.0b013e31815daf1a]

  • Pallares, Judit; Velasco, Ana; Eritja, Nuria; Santacana, Maria; Dolcet, Xavier; Cuatrecasas, Miriam; Palomar-Asenjo, Victor; Catasus, Lluis; Prat, Jaime; Matias-Guiu, Xavier

    Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma.

    Modern Pathology 21 691-699. .

    [doi:10.1038/modpathol.2008.38]

Projectes

  • Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • Estudio metabolómico del carcinoma de endometrio en relación a parametros morfológicos y moleculares
  • Carcinoma de endometrio. Participación de las vías de señalización, implicadas en la resistencia a la terapia antineoplasica
  • CARCINOMA DE ENDOMETRIO. VALORACION DELECCIONES Y AMPLIFICACIONES DE REGIONES CROMOSOMICAS MEDIANTE ARRAYS DE CGH
  • Alteraciones de la modulación de la vía RAS-MAPK y PI-3K en el cáncer de endometrio RASSF1A, NORE1A, Sprouty y PI3CA